CD276 and neoplasm: Both GPC2 and CD276 CAR T cells failed to control tumor growth, due to the dominance of CD276+ and GPC2+ cells respectively, whereas the BiCisCAR T cells were able to completely eradicate leukemia and prevent recurrence (7).